Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Novartis lifts 2013 guidance on delay to Diovan generics

Novartis lifts 2013 guidance on delay to Diovan generics Jimenez also said Novartis had a fertile quarter in terms of its pipeline, with four approvals including Ilaris (canakinumab) for systemic juvenile idiopathic arthritis, Simbrinza (brinzolamide/brimonidine tartrate) for glaucoma, Lucentis

Lucentis cleared in Europe for pathological myopia

Lucentis cleared in Europe for pathological myopia Makes Novartis' drug the first anti-VEGF approved in this setting. Novartis has been given a green light in the EU for the use of its Lucentis product in the treatment ... Specifically, Lucentis (ranibizumab) has been approved by the European Commission

Eylea set to challenge Lucentis in UK after NICE recommendation

Eylea set to challenge Lucentis in UK after NICE recommendation Novartis has seen its drug Lucentis (ranibizumab) become the standard-of-care in the country for wet AMD – the most common cause of blindness in the western world – after it was ... However, Eylea (aflibercept) today received final draft guidance

Novartis wins third NICE recommendation for Lucentis

Novartis wins third NICE recommendation for Lucentis This adds to a recommendation in February 2013 for the use of Lucentis to treat diabetes-related macular oedema and a 2008 recommendation to treat age-related macular degeneration. ... However, as with Lucentis' previous NICE recommendations, Novartis

NICE turns down Novartis’ blood cancer drug Jakavi

NICE turns down Novartis’ blood cancer drug Jakavi for several other products, including Gilenya, Tasigna and Lucentis, that were subsequently given the green light.

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...